Pediatrix Medical Group, Inc. (MD)

Pediatrix Medical Group Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	162.19	-99.07	-60.41	66.34	130.96	-796.49
Depreciation & Amortization	23.07	32.23	36.17	35.64	32.15	28.44
Loss (Gain) From Sale of Assets	-22.14	9.7	-	-	-7.28	-
Asset Writedown & Restructuring Costs	-3.6	178.44	148.31	-	-	-
Loss (Gain) From Sale of Investments	-	-	20	-	-	-
Stock-Based Compensation	15.44	11.87	12.32	16.13	18.97	39.04
Other Operating Activities	37.99	-4.15	1.31	32.39	-37.67	830.17
Change in Accounts Receivable	38.76	10.29	26.28	-5.54	-72.73	37.94
Change in Accounts Payable	46.46	51.14	-11.92	0.42	21.33	47.91
Change in Income Taxes	-3.19	-5.04	-21.68	18.23	-2.29	-6.93
Change in Other Net Operating Assets	-0.03	31.84	-4.31	18.73	30.32	-26.19
Operating Cash Flow	290	206.57	137.33	166.94	76.74	204.62
Operating Cash Flow Growth	103.06%	50.43%	-17.74%	117.55%	-62.50%	-42.80%
Capital Expenditures	-16.61	-22.02	-33.33	-29.71	-32.25	-28.79
Sale of Property, Plant & Equipment	-	-	-	-	24.73	-
Cash Acquisitions	-19.2	-8.17	-6.67	-28.17	-29.93	-2.23
Investment in Securities	-5.03	-12.05	-8.99	-0.46	-18.56	-28.41
Other Investing Activities	0.89	6.84	0.81	1.38	2.93	874.94
Investing Cash Flow	-9.95	-35.41	-48.18	-56.95	-53.07	815.51
Long-Term Debt Issued	-	235.5	470	1,480	-	527.5
Long-Term Debt Repaid	-	-250.89	-489.12	-1,885	-762.66	-528.66
Net Debt Issued (Repaid)	-19.38	-15.39	-19.12	-405.17	-762.66	-1.16
Issuance of Common Stock	3.27	3.64	4.91	5.4	6.85	7.01
Repurchase of Common Stock	-23.29	-1.7	-0.92	-88.51	-4.72	-8.49
Other Financing Activities	-4.42	-1.03	-10.59	0.73	0.41	-1.51
Financing Cash Flow	-43.82	-14.49	-25.72	-487.55	-760.12	-4.16
Net Cash Flow	236.23	156.68	63.43	-377.57	-736.45	1,016
Free Cash Flow	273.39	184.55	104	137.23	44.49	175.83
Free Cash Flow Growth	137.34%	77.46%	-24.22%	208.47%	-74.70%	-48.05%
Free Cash Flow Margin	14.22%	9.17%	5.21%	6.96%	2.33%	10.14%
Free Cash Flow Per Share	3.21	2.21	1.26	1.63	0.52	2.11
Cash Interest Paid	40	40	42.28	116.24	86.54	110.49
Cash Income Tax Paid	4.67	4.67	30.84	26.91	54.73	-27.78
Levered Free Cash Flow	217.22	173.92	69.2	136.08	61.19	205.21
Unlevered Free Cash Flow	240.31	199.39	95.5	160.89	104.14	274.26
Change in Working Capital	82	88.24	-11.63	31.83	-23.37	52.73

Updated Nov 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q